VE-Cadherin Antibody [Unconjugated]

Western blot shows lysates of mouse lung tissue and bEnd.3 mouse endothelioma cell line. PVDF membrane was probed with 0.2 µg/mL of Goat Anti-Mouse VE‑Cadherin Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1002) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF017). A specific band was detected for VE‑Cadherin at approximately 120 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.

VE‑Cadherin was detected in immersion fixed paraffin-embedded sections of mouse heart using Goat Anti-Mouse VE‑Cadherin Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1002) at 3 µg/mL for 1 hour at room temperature followed by incubation with the Anti-Goat IgG VisUCyte™ HRP Polymer Antibody (Catalog # VC004). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to cell membranes. View our protocol for IHC Staining with VisUCyte HRP Polymer Detection Reagents.

Simple Western lane view shows lysates of mouse lung tissue, loaded at 0.2 mg/mL. Specific bands were detected for VE‑Cadherin at approximately 118, 146 kDa (as indicated) using 10 µg/mL of Goat Anti-Mouse VE‑Cadherin Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1002) . This experiment was conducted under reducing conditions and using the 12‑230 kDa separation system.

Resting skin vessels contain high density HS moieties preferentially expressed at their basolateral compartments.(A, C, E, F, G) Axial and longitudinal sections of vessels of (A, B) naïve frozen, or (C, D, E, F, G) paraffin embedded murine flank skin tissues. Tissues were stained for HS with monoclonal mouse IgM (10E4 epitope; red), goat anti mouse VE-cadherin (cyan), FITC-mouse monoclonal to alpha -SMA (green), and nuclei (blue). (H) HS and alpha -SMA profile of the fluorescence intensity along the purple arrow in the merged image. Double-headed black arrow denotes the vessel lumen as indicated by VE-cadherin. In C, D and G, small-headed arrows denote the endothelial apical side, large-headed arrows denote the endothelial basolateral side, and broken-line arrows denote the pericyte basolateral side. Images were taken at 100X magnification. Scale bar represents 5 µm. Image collected and cropped by CiteAb from the following publication (//dx.plos.org/10.1371/journal.pone.0085699), licensed under a CC-BY license. Not internally tested by R&D Systems.

Chronic intermittent hypoxia modifies the BM vascular structure. a’–e’ Representative images of femur bone marrow stained with vWF, CD105, VE-cadherin, SMA, and CD11b counterstained with hematoxylin. a”, c”, d” BM from CIH exposed rats (n = 6) has more VE-cadherin+ vessels and SMA coverage but less vWF+ sinusoids (400×, Leica DM2500). e’, e” Representative images of CD11b immunohistochemistry in femur BM show an increase in BM monocyte count in CIH exposed animals. (400×, Leica DM2500) a’, a”’, b’, b” No changes in the total number of vessels or in megakaryocyte count were observed, as accounted by CD105 and vWF staining, respectively. Results are represented as the mean ± SD of bone marrow sections from six male Wistar rats (*p AF1002) at 3ug/mL with 1 hour incubation at room temperature followed by incubation with anti-goat IgG VisUCyte HRP Polymer Antibody (Catalog # VC004) and DAB chromogen (yellow-brown). Tissue was counterstained with hematoxylin (blue). Specific staining was localized to cardiac myocytes.

Warfarin pretreatment enhances tumor Ad5ROBO4 vector expression.A. Multiorgan immunoblot of vehicle (left lanes) or warfarin (right lanes) pretreated Rag2−/− mice injected with 1.0×1011 vp of Ad5ROBO4. B. Densitometry of A revealed that vehicle pretreatment was associated with robust liver, detectable splenic, and trace to undetectable expression in all other sampled organs. Warfarin pretreatment produced a 2.5-fold increased splenic and a 3-fold decreased liver expression while all other organs still evidenced trace to undetectable expression. C. Immunoblot and densitometry of liver and tumor EGFP, VE-cadherin, and beta -tubulin expression in vehicle (left lanes) or warfarin (right lanes) from the same pretreated, Ad5ROBO4-injected mice as in A and B. EGFP densitometry normalized to VE-cadherin, revealed a 4.7-fold decrease in liver and 2-fold increase in increase KO and SC tumor expression produced by warfarin pretreatment. A–C: representative immunoblots from n = 2 mice from 2 independent experiments. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/24376772), licensed under a CC-BY license. Not internally tested by R&D Systems.

Semiquantitative immunoblotting reveals differential Ad5ROBO4 reporter expression in tumor compared to liver.A. Immunoblot of EGFP, VE-cadherin, and beta -tubulin loading controls in tissue protein extracts from hCAR:Rag2−/− mice injected with either Ad5ROBO4, left three lanes, or Ad5CMV, right three lanes. B. and C. Densitometry analysis of Ad5ROBO4 vector EGFP expression normalized to either VE-cadherin or beta -tubulin. D. Densitometry of AdCMV vector EGFP expression. As AdCMV expression was hepatocyte specific, this blot was only normalized to beta -tubulin. A–D: Representative immunoblots from n = 4 mice injected with either Ad5ROBO 4 or Ad5CMV vectors. Li: liver, KO: kidney orthotopic tumor, SC: subcutaneous tumor. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/24376772), licensed under a CC-BY license. Not internally tested by R&D Systems.

Endogenous ROBO4 upregulation despite lower vascular density in orthotopic and xenograft tumors.A. Immunofluorescence of the vascular endothelium in liver (upper panel) and 786-O human renal cell carcinoma (RCC) subcutaneous xenograft tumor (lower panel). B. Vascular area analysis of liver (Li), kidney orthotopic (KO) tumors, and subcutaneous (SC) xenograft tumors (n = 6 mice analyzed). C. Immunoblot of endogenous ROBO4 and the endothelial cell specific VE-cadherin from liver, kidney orthotopic and subcutaneous xenograft 786-O RCC tumors, and from the derivative 786-O cells grown in culture. D. Densitometry analysis of VE-cadherin/tubulin ratio from C mirrors the vascular area determination in B. E. Densitometry analysis of endogenous ROBO4 normalized to VE-cadherin expression reveals a 1.4- to 2-fold increase in SC and KO tumors compared to liver. C–E: Immunoblot and densitometry was repeated twice with two independent sets of protein extracts from two different tumor-bearing mice with essentially the same results. A. Magnification: 100X, Red: endomucin/CD31 antibody cocktail, Blue: DAPI. B. *p<0.05, one way ANOVA with Tukey's correction, mean ± SD. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/24376772), licensed under a CC-BY license. Not internally tested by R&D Systems.

Warfarin pretreatment enhances tumor Ad5ROBO4 vector expression.A. Multiorgan immunoblot of vehicle (left lanes) or warfarin (right lanes) pretreated Rag2−/− mice injected with 1.0×1011 vp of Ad5ROBO4. B. Densitometry of A revealed that vehicle pretreatment was associated with robust liver, detectable splenic, and trace to undetectable expression in all other sampled organs. Warfarin pretreatment produced a 2.5-fold increased splenic and a 3-fold decreased liver expression while all other organs still evidenced trace to undetectable expression. C. Immunoblot and densitometry of liver and tumor EGFP, VE-cadherin, and beta -tubulin expression in vehicle (left lanes) or warfarin (right lanes) from the same pretreated, Ad5ROBO4-injected mice as in A and B. EGFP densitometry normalized to VE-cadherin, revealed a 4.7-fold decrease in liver and 2-fold increase in increase KO and SC tumor expression produced by warfarin pretreatment. A–C: representative immunoblots from n = 2 mice from 2 independent experiments. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/24376772), licensed under a CC-BY license. Not internally tested by R&D Systems.

Deletion of VE-cadherin in CYP19A1(Tg)Cre; Cdh5fl/fl placentas.(A, B) Immunofluorescence staining and quantification of E12.5 Control and CYP19A1(Tg)Cre; Cdh5fl/fl placentas for VE-cadherin (green) and CK8 (red). Yellow arrowheads indicate VE-cadherin+ trophoblasts, which predominantly line remodeled spiral arteries. White arrowheads indicate VE-cadherin- trophoblasts. Red arrowheads indicate spiral artery endothelial cells (ECs), which are VE-cadherin+ CK8-. VE-cadherin and CK8 colocalized area was divided by total CK8-positive area to determine the extent of VE-cadherin deletion. Note that there are a few VE-cadherin+ trophoblasts in CYP19A1(Tg)Cre; Cdh5fl/fl placentas, however VE-cadherin is deleted from the majority of trophoblasts. The layer of VE-cadherin+ CK8- cells (red arrowheads) in the CYP19A1(Tg)Cre; Cdh5fl/fl placentas are spiral artery endothelial cells that have not been displaced by trophoblasts. Dotted white lines demarcate the decidua and junctional zone (JZ). Positive signal in small, rounded cells in the lumen is the result of erythrocyte autofluorescence. Control n = 4, CYP19A1(Tg)Cre; Cdh5fl/fl n = 3. Scale bars = 100 μm. (C, D) E12.5 placental and embryo weights do not differ between Cre-negative (Cdh5fl/+ or Cdh5fl/fl) and Cre-positive heterozygous (CYP19A1(Tg)Cre; Cdh5fl/fl) controls. Statistical analysis was performed using two-tailed, unpaired Welch’s t-test. Data are shown as means ± SD.Figure 1—figure supplement 1—source data 1.Excel file containing quantification for VE-cadherin expression in trophoblasts, embryo weights, and placenta weights in Figure 1—figure supplement 1.Excel file containing quantification for VE-cadherin expression in trophoblasts, embryo weights, and placenta weights in Figure 1—figure supplement 1. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/35486098), licensed under a CC-BY license. Not internally tested by R&D Systems.

VE-cadherin expression is retained in the vasculature of affected organs in CYP19A1(Tg)Cre; Cdh5fl/fl embryos.(A) Immunofluorescence staining of E12.5 Control and CYP19A1(Tg)Cre; Cdh5fl/fl brains for VE-cadherin (green) and Endomucin (red) at sites of hemorrhage. Images in gray scale are VE-cadherin alone. Red arrowheads point to extravascular autofluorescent erythrocytes. Yellow arrowheads point to VE-cadherin+ vessels. Scale bars = 50 μm. (B) Immunofluorescence staining of E12.5 Control and CYP19A1(Tg)Cre; Cdh5fl/fl hearts for VE-cadherin (green) and Endomucin (red). Images in gray scale are VE-cadherin alone. Red arrowheads point to VE-cadherin+ developing coronary vessels. Yellow arrowheads point to VE-cadherin+ endocardium. Scale bars = 50 μm. (C) Immunofluorescence staining of E12.5 Control and CYP19A1(Tg)Cre; Cdh5fl/fl hearts for VE-cadherin (green), Endomucin (red), and LYVE1 (gray). Images in gray scale represent VE-cadherin pixels colocalized with either LYVE1 (liver) or Endomucin (lungs and thorax). Red arrowheads point to LYVE1+VE-cadherin+ liver sinusoidal vessels. Yellow arrowheads point to Endomucin+VE-cadherin+ lung and thoracic blood vessels. Scale bars = 200 μm. (D) Quantification of fold change in VE-cadherin mean fluorescence intensity in the brain, heart, liver, lungs, and thorax.Figure 1—figure supplement 3—source data 1.Excel file containing quantification for VE-cadherin expression in various organs in Figure 1—figure supplement 3.Excel file containing quantification for VE-cadherin expression in various organs in Figure 1—figure supplement 3. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/35486098), licensed under a CC-BY license. Not internally tested by R&D Systems.

VE-cadherin expression is retained in the vasculature of affected organs in CYP19A1(Tg)Cre; Cdh5fl/fl embryos.(A) Immunofluorescence staining of E12.5 Control and CYP19A1(Tg)Cre; Cdh5fl/fl brains for VE-cadherin (green) and Endomucin (red) at sites of hemorrhage. Images in gray scale are VE-cadherin alone. Red arrowheads point to extravascular autofluorescent erythrocytes. Yellow arrowheads point to VE-cadherin+ vessels. Scale bars = 50 μm. (B) Immunofluorescence staining of E12.5 Control and CYP19A1(Tg)Cre; Cdh5fl/fl hearts for VE-cadherin (green) and Endomucin (red). Images in gray scale are VE-cadherin alone. Red arrowheads point to VE-cadherin+ developing coronary vessels. Yellow arrowheads point to VE-cadherin+ endocardium. Scale bars = 50 μm. (C) Immunofluorescence staining of E12.5 Control and CYP19A1(Tg)Cre; Cdh5fl/fl hearts for VE-cadherin (green), Endomucin (red), and LYVE1 (gray). Images in gray scale represent VE-cadherin pixels colocalized with either LYVE1 (liver) or Endomucin (lungs and thorax). Red arrowheads point to LYVE1+VE-cadherin+ liver sinusoidal vessels. Yellow arrowheads point to Endomucin+VE-cadherin+ lung and thoracic blood vessels. Scale bars = 200 μm. (D) Quantification of fold change in VE-cadherin mean fluorescence intensity in the brain, heart, liver, lungs, and thorax.Figure 1—figure supplement 3—source data 1.Excel file containing quantification for VE-cadherin expression in various organs in Figure 1—figure supplement 3.Excel file containing quantification for VE-cadherin expression in various organs in Figure 1—figure supplement 3. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/35486098), licensed under a CC-BY license. Not internally tested by R&D Systems.

Microtubules (MT) are indispensable for VEGF-induced cell elongation. a Confluent HUVECs immune labelled for VE-cadherin, alpha -tubulin and Phalloidin-TRITC after VEGF treatment for 24 h or PBS for control, as indicated. Nuclei are stained blue with DAPI. LSM demonstrates MT in control cells evenly distributed throughout the cells, while a few MT are aligned in parallel with JAAF (red arrows). VEGF-induced elongated cells display MT running parallel to the longitudinal cell axis together with stress fibres, and MT are enriched at the leading edge (white arrows; for dynamics compare supplementary Movie 10) (Scale bar: 20 µm). The cropped area displays an interrupted VE-cadherin pattern, MT enrichment, and stress fibres at the cell poles (arrowheads; for dynamics compare Supplementary Movies 10 and 11) (scale bar: 10 µm). b Confluent HUVEC cultures treated with 50 ng ml−1 nocodazole for 4 h and subsequently labelled with VE-cadherin antibody and with Phallodin-TRITC for actin filaments. MT depolymerisation had less effect on the JAAF and VE-cadherin distribution (Scale bar: 20 µm). c–e Confluent HUVECs pre-treated with 50 ng ml−1 nocodazole for 30 min and then treated with VEGF for another 18 h. c Phase-contrast microscopy revealed that nocodazole inhibited VEGF-induced cell elongation (scale bar: 80 µm). Quantification of (d) cell velocity and (e) cell elongation using Fiji software (100 cells were analysed at t = 0, 100 cells at t = 9 h, 81 cells at t = 18 h for nocodazole+VEGF treatment; and 100 cells were analysed at each time point for VEGF treatment, unpaired student’s t test). noco: nocodazole. Representative results from three independent experiments are shown. Error bars indicate ± SEM Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/29263363), licensed under a CC-BY license. Not internally tested by R&D Systems.

VE-cadherin expression is retained in the vasculature of affected organs in CYP19A1(Tg)Cre; Cdh5fl/fl embryos.(A) Immunofluorescence staining of E12.5 Control and CYP19A1(Tg)Cre; Cdh5fl/fl brains for VE-cadherin (green) and Endomucin (red) at sites of hemorrhage. Images in gray scale are VE-cadherin alone. Red arrowheads point to extravascular autofluorescent erythrocytes. Yellow arrowheads point to VE-cadherin+ vessels. Scale bars = 50 μm. (B) Immunofluorescence staining of E12.5 Control and CYP19A1(Tg)Cre; Cdh5fl/fl hearts for VE-cadherin (green) and Endomucin (red). Images in gray scale are VE-cadherin alone. Red arrowheads point to VE-cadherin+ developing coronary vessels. Yellow arrowheads point to VE-cadherin+ endocardium. Scale bars = 50 μm. (C) Immunofluorescence staining of E12.5 Control and CYP19A1(Tg)Cre; Cdh5fl/fl hearts for VE-cadherin (green), Endomucin (red), and LYVE1 (gray). Images in gray scale represent VE-cadherin pixels colocalized with either LYVE1 (liver) or Endomucin (lungs and thorax). Red arrowheads point to LYVE1+VE-cadherin+ liver sinusoidal vessels. Yellow arrowheads point to Endomucin+VE-cadherin+ lung and thoracic blood vessels. Scale bars = 200 μm. (D) Quantification of fold change in VE-cadherin mean fluorescence intensity in the brain, heart, liver, lungs, and thorax.Figure 1—figure supplement 3—source data 1.Excel file containing quantification for VE-cadherin expression in various organs in Figure 1—figure supplement 3.Excel file containing quantification for VE-cadherin expression in various organs in Figure 1—figure supplement 3. Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/35486098), licensed under a CC-BY license. Not internally tested by R&D Systems.

Polarized distribution of VE-cadherin and actin in sprouting ECs in developing mice retinas. a Laser scanning microscopy (LSM) showing an overview of the front area of a whole-mounted P6 transgenic mouse retina expressing LifeAct-EGFP additionally immune stained with anti-VE-cadherin and anti-ERG antibodies; nuclei were stained with anti-ERG. Tip cell (arrowheads) and adjacent stalk cell (arrows) are indicated. Scale bar: 40 µm. b High-resolution SIM of selected areas 1–3, as indicated in the right panel of a. Shown is one z-plane. (Area 1) a characteristic tip cell with large actin-based filopodia and a cytosolic spotted VE-cadherin pattern. (Area 2) A tip cell/stalk cell junction at the cell pole of elongated cells identifies terminating actin filaments (arrow) and an interrupted VE-cadherin pattern (arrowhead). (Area 3) a stalk cell/stalk cell connection. VE-cadherin plaques are indicated at the cell poles (arrowheads) and a linear VE-cadherin pattern (empty arrowhead) at lateral junctions; parallel actin filaments are also visible. Scale bar: 5 µm. (Area 4) The cropped area depicts an actin-positive JAIL (dotted line, LifeAct-EGFP) with VE-cadherin plaques (dotted line, VE-cadherin staining). Scale bar: 2 µm. c P7 rat retina immune labelled with ARPC2 and VE-cadherin show increased ARPC2 at the cell poles (arrows). Scale bars in the left panels and right panels represent 50 and 15 µm, respectively. d Scheme illustrates the iterative dynamics of VE-cadherin interruption and JAIL formation leading to VE-cadherin plaques in sprouting ECs. The VE-cadherin dynamics was particularly pronounced at the cell poles, while the lateral junctions showed moderate dynamics Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/29263363), licensed under a CC-BY license. Not internally tested by R&D Systems.

Polarized distribution of VE-cadherin and actin in sprouting ECs in developing mice retinas. a Laser scanning microscopy (LSM) showing an overview of the front area of a whole-mounted P6 transgenic mouse retina expressing LifeAct-EGFP additionally immune stained with anti-VE-cadherin and anti-ERG antibodies; nuclei were stained with anti-ERG. Tip cell (arrowheads) and adjacent stalk cell (arrows) are indicated. Scale bar: 40 µm. b High-resolution SIM of selected areas 1–3, as indicated in the right panel of a. Shown is one z-plane. (Area 1) a characteristic tip cell with large actin-based filopodia and a cytosolic spotted VE-cadherin pattern. (Area 2) A tip cell/stalk cell junction at the cell pole of elongated cells identifies terminating actin filaments (arrow) and an interrupted VE-cadherin pattern (arrowhead). (Area 3) a stalk cell/stalk cell connection. VE-cadherin plaques are indicated at the cell poles (arrowheads) and a linear VE-cadherin pattern (empty arrowhead) at lateral junctions; parallel actin filaments are also visible. Scale bar: 5 µm. (Area 4) The cropped area depicts an actin-positive JAIL (dotted line, LifeAct-EGFP) with VE-cadherin plaques (dotted line, VE-cadherin staining). Scale bar: 2 µm. c P7 rat retina immune labelled with ARPC2 and VE-cadherin show increased ARPC2 at the cell poles (arrows). Scale bars in the left panels and right panels represent 50 and 15 µm, respectively. d Scheme illustrates the iterative dynamics of VE-cadherin interruption and JAIL formation leading to VE-cadherin plaques in sprouting ECs. The VE-cadherin dynamics was particularly pronounced at the cell poles, while the lateral junctions showed moderate dynamics Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/29263363), licensed under a CC-BY license. Not internally tested by R&D Systems.

JAIL formation&cell migration are blocked by Rac inhibition&VE-cadherin overexpression in scratch assay. a–f HUVECs scratched, allowed to grow for 5 h,&labelled for VE-cadherin&Phalloidin-TRITC. a Overviews of the migrating front (left upper)&centre area (left lower). (Area 1) interrupted VE-cadherin that co-localise with filopodia-like actin filaments (arrows). (Area 2) Large JAIL (arrowheads) at cell pole. (Area 3) small JAIL (arrowheads) at lateral junctions. (Area 4) Polygonal cells in the centre area. Scale bars represent 60 µm&15 µm in the overview&cropped images respectively. b, c Comparison of cell perimeter&Rel-VEcad-C in front&centre ECs. Quantification of (d) JAIL number&(e) JAIL size in front (n = 115 cells)&centre cells (n = 186 cells). f JAIL size at cell poles&lateral junctions in front ECs (n = 115 cells). P value was determined by unpaired student’s t test. Image collected & cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/29263363), licensed under a CC-BY license. Not internally tested by R&D Systems.

Polarized JAIL dynamics during sprouting angiogenesis in fibrin angiogenesis assay using EGFP-p20 expressing HUVECs.f Overview&Z-projections of vessel sprouts in fibrin angiogenesis assays 5 days after seeding; cells fixed&labelled with Phalloidin-TRITC&VE-cadherin. (cropped areas) JAIL are indicated at cell poles by the appearance of large VE-cadherin plaques (arrows) that co-localise with the actin network (arrows), whereas small VE-cadherin plaques appear at lateral junctions (arrowhead). Error bars represent ± SEM; scale bars indicate 50&10 µm in the overview&cropped areas, respectively Image collected & cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/29263363), licensed under a CC-BY license. Not internally tested by R&D Systems.

Polarized distribution of VE-cadherin and actin in sprouting ECs in developing mice retinas. a Laser scanning microscopy (LSM) showing an overview of the front area of a whole-mounted P6 transgenic mouse retina expressing LifeAct-EGFP additionally immune stained with anti-VE-cadherin and anti-ERG antibodies; nuclei were stained with anti-ERG. Tip cell (arrowheads) and adjacent stalk cell (arrows) are indicated. Scale bar: 40 µm. b High-resolution SIM of selected areas 1–3, as indicated in the right panel of a. Shown is one z-plane. (Area 1) a characteristic tip cell with large actin-based filopodia and a cytosolic spotted VE-cadherin pattern. (Area 2) A tip cell/stalk cell junction at the cell pole of elongated cells identifies terminating actin filaments (arrow) and an interrupted VE-cadherin pattern (arrowhead). (Area 3) a stalk cell/stalk cell connection. VE-cadherin plaques are indicated at the cell poles (arrowheads) and a linear VE-cadherin pattern (empty arrowhead) at lateral junctions; parallel actin filaments are also visible. Scale bar: 5 µm. (Area 4) The cropped area depicts an actin-positive JAIL (dotted line, LifeAct-EGFP) with VE-cadherin plaques (dotted line, VE-cadherin staining). Scale bar: 2 µm. c P7 rat retina immune labelled with ARPC2 and VE-cadherin show increased ARPC2 at the cell poles (arrows). Scale bars in the left panels and right panels represent 50 and 15 µm, respectively. d Scheme illustrates the iterative dynamics of VE-cadherin interruption and JAIL formation leading to VE-cadherin plaques in sprouting ECs. The VE-cadherin dynamics was particularly pronounced at the cell poles, while the lateral junctions showed moderate dynamics Image collected and cropped by CiteAb from the following open publication (//pubmed.ncbi.nlm.nih.gov/29263363), licensed under a CC-BY license. Not internally tested by R&D Systems.

• Reactivity: Mu
• Applications: WB, Simple Western, IHC, Dual ISH-IHC
• Clonality: Polyclonal
• Host: Goat
• Conjugate: Unconjugated
• Concentration: LYOPH

VE-Cadherin Antibody [Unconjugated] Summary

• Immunogen: Mouse myeloma cell line NS0-derived recombinant mouse VE-Cadherin
  Asp46-Gln592
  Accession # 2208309A
• Specificity: Detects mouse VE-Cadherin in direct ELISAs and Western blots. In direct ELISAs, approximately 30% cross‑reactivity with recombinant human VE-Cadherin is observed.
• Source: N/A
• Isotype: IgG
• Clonality: Polyclonal
• Host: Goat
• Gene: CDH5
• Purity Statement: Antigen Affinity-purified

Applications/Dilutions

• Dilutions:
  • Dual RNAscope ISH-IHC 5-15 ug/mL
  • Immunohistochemistry 3-25 ug/mL
  • Simple Western 10 ug/mL
  • Western Blot 0.2 ug/mL

Packaging, Storage & Formulations

• Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. See Certificate of Analysis for details.
  *Small pack size (-SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
• Preservative: No Preservative
• Concentration: LYOPH
• Reconstitution Instructions: Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for VE-Cadherin Antibody [Unconjugated]

• 7B4 antigen
• 7B4
• cadherin 5, type 2 (vascular endothelium)
• cadherin 5, type 2, VE-cadherin (vascular epithelium)
• Cadherin-5
• CD144 antigen
• CD144
• CDH5
• endothelial-specific cadherin
• FLJ17376
• Vascular endothelial cadherin
• VECadherin
• VE-Cadherin

Background

The cadherin (Ca⁺⁺-dependent adherence) superfamily is a large group of membrane-associated glycoproteins that engage in homotypic, calcium-dependent, cell-cell adhesion events. The superfamily can be divided into at least five major subfamilies based on molecule gene structure, and/or extracellular (EC) and intracellular domains (1-4). Subfamilies include classical/type I, atypical/type II, and desmosomal-related cadherins (1-3). VE-Cadherin (vascular endothelial cadherin; also cadherin-5 and CD144) is a 125 kDa atypical/type II subfamily cadherin. Its subfamily classification is based principally on its genomic structure, as its physical structure is notably divergent from other type II subfamily members (2, 3). Mouse VE-Cadherin is synthesized as a 784 amino acid (aa) type I transmembrane (TM) preproprotein that contains a 24 aa signal peptide, a 21 aa prosequence, a 554 aa extracellular region (ECR), a 21 aa TM segment, and a 164 aa cytoplasmic domain (5, 6). The ECR contains five Ca⁺⁺-binding cadherin domains that are approximately 105 aa in length. Cadherin domains are comprised of two beta ‑sheets that are oriented like bread in a sandwich. Although complex, the N-terminal cadherin domain mediates trans interactions, while the internal domains contribute to cis multimerizations (7). Mouse VE-Cadherin ECR is 92%, 77%, and 73% aa identical to rat, human and porcine VE-Cadherin ECR, respectively. VE-Cadherin is involved in the maintenance of endothelial permeability. In this regard, VE-Cadherin does not initiate new blood vessel formation; it maintains it once formed. Thus, when VE‑Cadherin is downregulated, cells part and permeability increases (8). Notably, VEGF is known to promote vascular leakage, and apparently does so by inducing a beta ‑arrestin-dependent endocytosis of VE-Cadherin (9). Part of this effect may be mediated by VE‑Cadherin itself which is reported to increase the membrane half-life of VEGF R2 (10). VE-Cadherin acts homotypically at sites of zonula adherens. On each expressing cell, it is proposed that VE-Cadherin first forms a trimer, which then dimerizes with a trimeric counterpart in-trans. Alternatively, two cis-dimers could act in-trans to generate homotypic binding (11). In addition to cell adhesion, VE‑Cadherin also is reported to mediate TGF-beta receptor assembly. When clustered, VE‑Cadherin enhances T beta RII/T beta RI assembly into an active receptor complex on endothelial cells (12). VE-Cadherin is expressed on endothelial cells, trophoblast cells, endothelial progenitor cells and embryonic hematopoietic cells (5, 8, 13, 14).

1. Patel, S.D. et al. (2007) Curr. Opin. Struct. Biol. 13:690.
2. Vestweber, D. (2008) Arterioscler. Thromb. Vasc. Biol. 28:223.
3. Vincent, P.A. et al. (2004) Am. J. Physiol. Cell. Physiol. 286:C987.
4. Cavallaro, U. et al. (2006) Exp. Cell Res. 312:659.
5. Breier, G. et al. (1996) Blood 87:630.
6. Huber, P. et al. (1996) Genomics 32:21.
7. Pokutta, S. and W.I. Weis (2007) Annu. Rev. Cell Dev. Biol. 23:237.
8. Crosby, C.V. et al. (2005) Blood 105:2771.
9. Gavard, J. and J.S. Gutkind (2006) Nat. Cell Biol. 8:1223.
10. Calera, M.R. et al. (2004) Exp. Cell Res. 300:248.
11. Hewat, E.A. et al. (2007) J. Mol. Biol. 365:744.
12. Rudini, N. et al. (2008) EMBO J. 27:993.
13. Kogata, N. et al. (2006) Circ. Res. 98:897.
14. Ema, M. et al. (2006) Blood 108:4018.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Publications for VE-Cadherin Antibody (AF1002)(121)

Publications using AF1002

• Pozzo, E;Yedigaryan, L;Giarratana, N;Wang, CC;Garrido, GM;Degreef, E;Marini, V;Rinaldi, G;van der Veer, BK;Sassi, G;Eelen, G;Planque, M;Fanzani, A;Koh, KP;Carmeliet, P;Yustein, JT;Fendt, SM;Uyttebroeck, A;Sampaolesi, M; miR-449a/miR-340 reprogram cell identity and metabolism in fusion-negative rhabdomyosarcoma Cell reports 2025-01-11 [PMID: 39799567] (Western Blot, Human)
• Kizhatil, K;Clark, GM;Sunderland, DK;Bhandari, A;Horbal, LJ;Balasubramanian, R;John, SWM; FYN regulates aqueous humor outflow and IOP through the phosphorylation of VE-CADHERIN Nature communications 2025-01-02 [PMID: 39746990] (Immunohistochemistry, Western Blot, Transgenic Mouse)
• Xue, L;Zhao, G;Gong, N;Han, X;Shepherd, SJ;Xiong, X;Xiao, Z;Palanki, R;Xu, J;Swingle, KL;Warzecha, CC;El-Mayta, R;Chowdhary, V;Yoon, IC;Xu, J;Cui, J;Shi, Y;Alameh, MG;Wang, K;Wang, L;Pochan, DJ;Weissman, D;Vaughan, AE;Wilson, JM;Mitchell, MJ; Combinatorial design of siloxane-incorporated lipid nanoparticles augments intracellular processing for tissue-specific mRNA therapeutic delivery Nature nanotechnology 2024-10-01 [PMID: 39354147] (Immunohistochemistry, Mouse)
• Park, H;Song, J;Jeong, HW;Grönloh, MLB;Koh, BI;Bovay, E;Kim, KP;Klotz, L;Thistlethwaite, PA;van Buul, JD;Sorokin, L;Adams, RH; Apelin modulates inflammation and leukocyte recruitment in experimental autoimmune encephalomyelitis Nature communications 2024-07-25 [PMID: 39060233] (Immunohistochemistry, Mouse)
• Halder, SK;Sapkota, A;Milner, R; ?1 integrins play a critical role maintaining vascular integrity in the hypoxic spinal cord, particularly in white matter Acta neuropathologica communications 2024-03-20 [PMID: 38509621] (Immunohistochemistry, Mouse)
• Chen, D;Wiggins, D;Sevick, EM;Davis, MJ;King, PD; An EPHB4-RASA1 signaling complex inhibits shear stress-induced Ras-MAPK activation in lymphatic endothelial cells to promote the development of lymphatic vessel valves bioRxiv : the preprint server for biology 2023-11-23 [PMID: 38045382] (IHC, Mouse)
• Kizhatil, K;Clark, G;Sunderland, D;Bhandari, A;Horbal, L;Balasubramanian, R;John, S; FYN regulates aqueous humor outflow and IOP through the phosphorylation of VE-cadherin bioRxiv : the preprint server for biology 2023-09-04 [PMID: 37886565] (IHC, Western Blot, Transgenic Mouse)
• Kaneko, K;Liang, Y;Liu, Q;Zhang, S;Scheiter, A;Song, D;Feng, GS; Identification of CD133+ intercellsomes in intercellular communication to offset intracellular signal deficit eLife 2023-10-17 [PMID: 37846866] (IHC, Mouse)
• He, S;Guo, Z;Zhou, M;Wang, H;Zhang, Z;Shi, M;Li, X;Yang, X;He, L; Spatial-temporal proliferation of hepatocytes during pregnancy revealed by genetic lineage tracing Cell stem cell 2023-09-27 [PMID: 37794588] (IHC, Transgenic Mouse)
• Chovatiya, G;Li, KN;Li, J;Ghuwalewala, S;Tumbar, T; Alk1 acts in non-endothelial VE-cadherin+ perineurial cells to maintain nerve branching during hair homeostasis Nature communications 2023-09-12 [PMID: 37699906] (IHC, Transgenic Mouse)
• Thatcher, K;Mattern, CR;Chaparro, D;Goveas, V;McDermott, MR;Fulton, J;Hutcheson, JD;Hoffmann, BR;Lincoln, J; Temporal Progression of Aortic Valve Pathogenesis in a Mouse Model of Osteogenesis Imperfecta Journal of cardiovascular development and disease 2023-08-20 [PMID: 37623368] (IHC, Mouse)
• Zhang, T;Xu, D;Liu, J;Wang, M;Duan, LJ;Liu, M;Meng, H;Zhuang, Y;Wang, H;Wang, Y;Lv, M;Zhang, Z;Hu, J;Shi, L;Guo, R;Xie, X;Liu, H;Erickson, E;Wang, Y;Yu, W;Dang, F;Guan, D;Jiang, C;Dai, X;Inuzuka, H;Yan, P;Wang, J;Babuta, M;Lian, G;Tu, Z;Miao, J;Szabo, G;Fong, GH;Karnoub, AE;Lee, YR;Pan, L;Kaelin, WG;Yuan, J;Wei, W; Prolonged hypoxia alleviates prolyl hydroxylation-mediated suppression of RIPK1 to promote necroptosis and inflammation Nature cell biology 2023-07-03 [PMID: 37400498] (IHC, Mouse)
• Cornuault, L;Hérion, FX;Bourguignon, C;Rouault, P;Foussard, N;Alzieu, P;Chapouly, C;Gadeau, AP;Couffinhal, T;Renault, MA; Partial Mural Cell Ablation Disrupts Coronary Vasculature Integrity and Induces Systolic Dysfunction Journal of the American Heart Association 2023-06-22 [PMID: 37345826] (Immunohistochemistry, Transgenic Mouse)
• Mi-Rae Park, Hye-Jin Lee, Hye-Min Jang, Nam Hoon Kim, Jun-Seok Lee, Yong Taek Jeong et al. Cytarabine induces cachexia with lipid malabsorption via zippering the junctions of lacteal in murine small intestine Journal of Lipid Research 2023-06-01 [PMID: 37201659] (Immunohistochemistry, Mouse)
• Hao, X;Shen, Y;Chen, N;Zhang, W;Valverde, E;Wu, L;Chan, HL;Xu, Z;Yu, L;Gao, Y;Bado, I;Michie, LN;Rivas, CH;Dominguez, LB;Aguirre, S;Pingel, BC;Wu, YH;Liu, F;Ding, Y;Edwards, DG;Liu, J;Alexander, A;Ueno, NT;Hsueh, PR;Tu, CY;Liu, LC;Chen, SH;Hung, MC;Lim, B;Zhang, XH; Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal Cell stem cell 2023-05-04 [PMID: 37146584] (IHC, Mouse)
• R Wang, C Ni, X Lou, L Zhang, L Wang, X Yao, X Duan, J Wan, P Li, Z Qin IFNgamma blockade in capillary leak site improves tumour chemotherapy by inhibiting lactate-induced endocytosis of vascular endothelial-cadherins International journal of biological sciences, 2023-02-27;19(5):1490-1508. 2023-02-27 [PMID: 37056922] (IHC, Western Blot, ICC, Mouse)
• Jiang H, Bai L, Song S et al. EZH2 controls epicardial cell migration during heart development Life science alliance 2023-06-01 [PMID: 37037595]
• H Liu, R Duan, X He, J Qi, T Xing, Y Wu, L Zhou, L Wang, Y Shao, F Zhang, H Zhou, X Gu, B Lin, Y Liu, Y Wang, Y Liu, L Li, D Liang, YH Chen Endothelial deletion of PTBP1 disrupts ventricular chamber development Nature Communications, 2023-03-31;14(1):1796. 2023-03-31 [PMID: 37002228] (IHC, Mouse)
• Colin Niaudet, Bongnam Jung, Andrew Kuo, Steven Swendeman, Edward Bull, Takahiro Seno et al. Therapeutic activation of endothelial sphingosine‐1‐phosphate receptor 1 by chaperone‐bound S1P suppresses proliferative retinal neovascularization EMBO Molecular Medicine 2023-05-08 [PMID: 36912000]
• E Lee, EA Lee, E Kong, H Chon, M Llaiqui-Co, CH Park, BY Park, NR Kang, JS Yoo, HS Lee, HS Kim, SH Park, SW Choi, D Vestweber, JH Lee, P Kim, WS Lee, I Kim An agonistic anti-Tie2 antibody suppresses the normal-to-tumor vascular transition in the glioblastoma invasion zone Experimental & Molecular Medicine, 2023-02-24;55(2):470-484. 2023-02-24 [PMID: 36828931] (IHC, Mouse)
• K Shirakura, P Baluk, AF Nottebaum, U Ipe, KG Peters, DM McDonald, D Vestweber Shear stress control of vascular leaks and atheromas through Tie2 activation by VE-PTP sequestration Embo Molecular Medicine, 2023-02-06;0(0):e16128. 2023-02-06 [PMID: 36740996] (IHC, Mouse)
• J Kazenwadel, P Venugopal, A Oszmiana, J Toubia, L Arriola-Ma, V Panara, SG Piltz, C Brown, W Ma, AW Schreiber, K Koltowska, S Taoudi, PQ Thomas, HS Scott, NL Harvey A Prox1 enhancer represses haematopoiesis in the lymphatic vasculature Nature, 2023-01-25;614(7947):343-348. 2023-01-25 [PMID: 36697821] (IHC, Mouse)
• Madhurima Paul, Shreeta Chakraborty, Safirul Islam, Rupasri Ain Trans-differentiation of trophoblast stem cells: implications in placental biology Life Science Alliance 2023-03-01 [PMID: 36574992]
• Yanrong Long, Hongbin Chen, Junchao Deng, Junjie Ning, Pengbo Yang, Lina Qiao et al. Deficiency of endothelial FGFR1 alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice Frontiers in Pharmacology 2022-11-18 [PMID: 36467073] (Immunohistochemistry, Mouse)
• F Baganha, TJ Sluiter, RCM de Jong, LA van Alst, HAB Peters, JW Jukema, M Delibegovi, K Pettersson, PHA Quax, MR de Vries Phosphorylcholine Monoclonal Antibody Therapy Decreases Intraplaque Angiogenesis and Intraplaque Hemorrhage in Murine Vein Grafts International Journal of Molecular Sciences, 2022-11-07;23(21):. 2022-11-07 [PMID: 36362449] (IHC, Mouse)
• Bowen Zhao, Yueqi Ni, Hong Zhang, Yin Zhao, Lu Li Endothelial deletion of TBK1 contributes to BRB dysfunction via CXCR4 phosphorylation suppression Cell Death Discovery 2022-10-28 [PMID: 36307391]
• W Zhang, Z Xu, X Hao, T He, J Li, Y Shen, K Liu, Y Gao, J Liu, D Edwards, AM Muscarella, L Wu, L Yu, L Xu, X Chen, YH Wu, IL Bado, Y Ding, S Aguirre, H Wang, Z Gugala, RL Satcher, ST Wong, XH Zhang Bone metastasis initiation is coupled with bone remodeling through osteogenic differentiation of NG2+ cells Cancer Discovery, 2023-02-06;0(0):. 2023-02-06 [PMID: 36287038] (IHC, Transgenic Mouse)
• F. Corti, E. Ristori, F. Rivera-Molina, D. Toomre, J. Zhang, J. Mihailovic et al. Syndecan-2 selectively regulates VEGF-induced vascular permeability Nature Cardiovascular Research 2022-10-10 [PMID: 36212522]
• Laura Maeso-Alonso, Hugo Alonso-Olivares, Nicole Martínez-García, Lorena López-Ferreras, Javier Villoch-Fernández, Laura Puente-Santamaría et al. p73 is required for vessel integrity controlling endothelial junctional dynamics through Angiomotin Cellular and Molecular Life Sciences 2022-10-01 [PMID: 36180740]
• R Hashimoto, J Takahashi, K Shirakura, R Funatsu, K Kosugi, S Deguchi, M Yamamoto, Y Tsunoda, M Morita, K Muraoka, M Tanaka, T Kanbara, S Tanaka, S Tamiya, N Tokunoh, A Kawai, M Ikawa, C Ono, K Tachibana, M Kondoh, M Obana, Y Matsuura, A Ohsumi, T Noda, T Yamamoto, Y Yoshioka, YS Torisawa, H Date, Y Fujio, M Nagao, K Takayama, Y Okada SARS-CoV-2 disrupts respiratory vascular barriers by suppressing Claudin-5 expression Science Advances, 2022-09-21;8(38):eabo6783. 2022-09-21 [PMID: 36129989] (Western Blot, Human, Mouse)
• Mengyun Hong, Yubiao Wu, Haiyi Zhang, Jinchao Gu, Juanjuan Chen, Yancheng Guan et al. Network pharmacology and experimental analysis to reveal the mechanism of Dan-Shen-Yin against endothelial to mesenchymal transition in atherosclerosis Frontiers in Pharmacology 2022-08-24 [PMID: 36091823]
• John D. Belcher, Julia Nguyen, Chunsheng Chen, Fuad Abdulla, Ruan Conglin, Zalaya K. Ivy et al. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease Translational Research 2022-11-01 [PMID: 35878790]
• M Moulis, SVM Runser, L Glorieux, N Dauguet, C Vanderaa, L Gatto, D Tyteca, P Henriet, FM Spagnoli, D Iber, CE Pierreux Identification and implication of tissue-enriched ligands in epithelial-endothelial crosstalk during pancreas development Scientific Reports, 2022-07-21;12(1):12498. 2022-07-21 [PMID: 35864120] (IHC, Mouse)
• Mark Richards, Emmanuel Nwadozi, Sagnik Pal, Pernilla Martinsson, Mika Kaakinen, Marleen Gloger et al. Claudin5 protects the peripheral endothelial barrier in an organ and vessel-type-specific manner eLife 2022-07-21 [PMID: 35861713]
• Raghu P. Kataru, Hyeung Ju Park, Jinyeon Shin, Jung Eun Baik, Ananta Sarker, Stav Brown et al. Structural and Functional Changes in Aged Skin Lymphatic Vessels Frontiers in Aging 2022-04-04 [PMID: 35821848]
• N Tisch, C Mogler, A Stojanovic, R Luck, EA Korhonen, A Ellerkmann, H Adler, M Singhal, G Schermann, L Erkert, JV Patankar, A Karakatsan, AL Scherr, Y Fuchs, A Cerwenka, S Wirtz, BC Köhler, HG Augustin, C Becker, T Schmidt, C Ruiz de Al Caspase-8 in endothelial cells maintains gut homeostasis and prevents small bowel inflammation in mice Embo Molecular Medicine, 2022-05-02;0(0):e14121. 2022-05-02 [PMID: 35491615] (IHC, Mouse)
• A Tarafdar, N Wolska, C Krisp, H Schlüter, G Pula The amyloid peptide beta disrupts intercellular junctions and increases endothelial permeability in a NADPH oxidase 1-dependent manner Redox Biology, 2022-03-25;52(0):102287. 2022-03-25 [PMID: 35358850] (Immunohistochemistry, Mouse)
• Brandon Hadland, Barbara Varnum-Finney, Stacey Dozono, Tessa Dignum, Cynthia Nourigat-McKay, Adam M. Heck et al. Engineering a niche supporting hematopoietic stem cell development using integrated single-cell transcriptomics Nature Communications 2022-03-24 [PMID: 35332125] (Immunohistochemistry, Mouse)
• CN Duong, R Brückner, M Schmitt, AF Nottebaum, L Braun, MM Zu Brickwe, U Ipe, H Vom Bruch, HR Schöler, G Trapani, B Trappmann, MP Ebrahimkut, S Huveneers, J Rooij, N Ishiyama, M Ikura, D Vestweber Force-induced changes of alpha-catenin conformation stabilize vascular junctions independent of vinculin Journal of Cell Science, 2021-12-22;0(0):. 2021-12-22 [PMID: 34851405] (ICC, Mouse)
• JM Arpino, H Yin, EK Prescott, SCR Staples, Z Nong, F Li, J Chevalier, B Balint, C O'Neil, R Mortuza, S Milkovich, JJ Lee, D Lorusso, M Sandig, DW Hamilton, DW Holdsworth, TL Poepping, CG Ellis, JG Pickering Low-flow intussusception and metastable VEGFR2 signaling launch angiogenesis in ischemic muscle Science Advances, 2021-11-26;7(48):eabg9509. 2021-11-26 [PMID: 34826235] (IHC, Mouse)
• S Heino, S Fang, M Lähde, J Högström, S Nassiri, A Campbell, D Flanagan, A Raven, M Hodder, N Nasreddin, HH Xue, M Delorenzi, S Leedham, TV Petrova, O Sansom, K Alitalo Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas Science Advances, 2021-11-17;7(47):eabj0512. 2021-11-17 [PMID: 34788095] (IHC, Mouse)
• Philipp-Sebastian Koch, Kajetan Sandorski, Joschka Heil, Christian D. Schmid, Sina W. Kürschner, Johannes Hoffmann et al. Imbalanced Activation of Wnt-/ beta -Catenin-Signaling in Liver Endothelium Alters Normal Sinusoidal Differentiation Frontiers in Physiology 2021-09-29 [PMID: 34658910]
• Nordquist EM, Dutta P, Kodigepalli KM et al. Tgf?1-Cthrc1 Signaling Plays an Important Role in the Short-Term Reparative Response to Heart Valve Endothelial Injury Arteriosclerosis, Thrombosis, and Vascular Biology 2021-12-01 [PMID: 34645278]
• M Mesnieres, AM Böhm, N Peredo, D Trompet, R Valle-Tenn, M Bajaj, N Corthout, E Nefyodova, R Cardoen, P Baatsen, S Munck, A Nagy, JJ Haigh, S Khurana, CM Verfaillie, C Maes Fetal hematopoietic stem cell homing is controlled by VEGF regulating the integrity and oxidative status of the stromal-vascular bone marrow niches Cell Reports, 2021-08-24;36(8):109618. 2021-08-24 [PMID: 34433017] (IHC, Mouse)
• Raghu P. Kataru, Jung Eun Baik, Hyeung Ju Park, Catherine L. Ly, Jinyeon Shin, Noa Schwartz et al. Lymphatic-specific intracellular modulation of receptor tyrosine kinase signaling improves lymphatic growth and function Science Signaling 2021-08-11 [PMID: 34376570]
• Qin Chen, Xiaoming Zhou, Ruonan Hou, Zhiliang Zhou, Zhiyi Wang, Ying Chen et al. Aminophylline modulates the permeability of endothelial cells via the Slit2‑Robo4 pathway in lipopolysaccharide‑induced inflammation Experimental and Therapeutic Medicine 2021-07-21 [PMID: 34373728]
• S Selbonne, C Madjene, B Salmon, Y Boulaftali, MC Bouton, V Arocas Protease nexin-1 deficiency increases mouse hindlimb neovascularisation following ischemia and accelerates femoral artery perfusion Scientific Reports, 2021-06-28;11(1):13412. 2021-06-28 [PMID: 34183729] (IHC, Mouse)
• M Richards, S Pal, E Sjöberg, P Martinsson, L Venkatrama, L Claesson-W Intra-vessel heterogeneity establishes enhanced sites of macromolecular leakage downstream of laminin &amp;alpha5 Cell Reports, 2021-06-22;35(12):109268. 2021-06-22 [PMID: 34161758] (IHC, Mouse)
• Takeshi Ninchoji, Dominic T Love, Ross O Smith, Marie Hedlund, Dietmar Vestweber, William C Sessa et al. eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin eLife 2021-04-28 [PMID: 33908348]
• Weijie Zhang, Igor L. Bado, Jingyuan Hu, Ying-Wooi Wan, Ling Wu, Hai Wang et al. The bone microenvironment invigorates metastatic seeds for further dissemination Cell 2021-04-01 [PMID: 33878291]
• Fabiana Baganha, Rob C. M. de Jong, Erna A. Peters, Wietske Voorham, J. Wouter Jukema, Mirela Delibegovic et al. Atorvastatin pleiotropically decreases intraplaque angiogenesis and intraplaque haemorrhage by inhibiting ANGPT2 release and VE-Cadherin internalization Angiogenesis 2021-08-01 [PMID: 33550461]
• E Russo, P Runge, NH Jahromi, H Naboth, A Landtwing, R Montecchi, N Leicht, MC Hunter, Y Takai, C Halin CD112 Regulates Angiogenesis and T Cell Entry into the Spleen Cells, 2021-01-15;10(1):. 2021-01-15 [PMID: 33467729] (ICC, IHC, Mouse)
• Anja Nitzsche, Riikka Pietilä, Dominic T Love, Chiara Testini, Takeshi Ninchoji, Ross O Smith et al. Paladin is a phosphoinositide phosphatase regulating endosomal VEGFR2 signalling and angiogenesis EMBO reports 2021-02-03 [PMID: 33369848] (Immunocytochemistry, Human)
• Gan Zhao, Aaron I. Weiner, Katherine M. Neupauer, Maria Fernanda de Mello Costa, Gargi Palashikar, Stephanie Adams-Tzivelekidis et al. Regeneration of the pulmonary vascular endothelium after viral pneumonia requires COUP-TF2 Science Advances 2020-11-27 [PMID: 33239293]
• Gan Zhao, Aaron I. Weiner, Katherine M. Neupauer, Maria Fernanda de Mello Costa, Gargi Palashikar, Stephanie Adams-Tzivelekidis et al. Regeneration of the pulmonary vascular endothelium after viral pneumonia requires COUP-TF2 Science Advances 11/27/2020 [PMID: 33239293]
• Pierre-Louis Hollier, Candice Chapouly, Aissata Diop, Sarah Guimbal, Lauriane Cornuault, Alain-Pierre Gadeau et al. Full-length Dhh and N-terminal Shh act as competitive antagonists to regulate angiogenesis and vascular permeability Cardiovascular Research 2021-11-01 [PMID: 33063110] (Immunohistochemistry, Mouse)
• Candice Chapouly, Pierre-Louis Hollier, Sarah Guimbal, Lauriane Cornuault, Alain-Pierre Gadeau, Marie-Ange Renault Desert Hedgehog-Driven Endothelium Integrity Is Enhanced by Gas1 (Growth Arrest-Specific 1) but Negatively Regulated by Cdon (Cell Adhesion Molecule-Related/Downregulated by Oncogenes) Arteriosclerosis, Thrombosis, and Vascular Biology 2020-12-01 [PMID: 33028094]
• Nicholas E. Propson, Ethan R. Roy, Alexandra Litvinchuk, Jörg Köhl, Hui Zheng Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging Journal of Clinical Investigation 2021-01-04 [PMID: 32990682]
• SJ Jeong, MJ Cho, NY Ko, S Kim, IH Jung, JK Min, SH Lee, JG Park, GT Oh Deficiency of peroxiredoxin 2 exacerbates angiotensin II-induced abdominal aortic aneurysm Exp. Mol. Med., 2020-09-14;0(0):. 2020-09-14 [PMID: 32929220] (Western Blot, Mouse)
• A Tabibian, S Ghaffari, DA Vargas, H Van Ooster, EAV Jones Simulating flow induced migration in vascular remodelling PLoS Comput. Biol., 2020-08-21;16(8):e1007874. 2020-08-21 [PMID: 32822340] (IHC, Mouse)
• SP Hong, MJ Yang, H Cho, I Park, H Bae, K Choe, SH Suh, RH Adams, K Alitalo, D Lim, GY Koh Distinct fibroblast subsets regulate lacteal integrity through YAP/TAZ-induced VEGF-C in intestinal villi Nat Commun, 2020-08-14;11(1):4102. 2020-08-14 [PMID: 32796823] (IHC, Mouse)
• Xingxing An, Ashley Ogawa-Wong, Colleen Carmody, Raffaele Ambrosio, Annunziata Gaetana Cicatiello, Cristina Luongo et al. A Type 2 Deiodinase-Dependent Increase in Vegfa Mediates Myoblast-Endothelial Cell Crosstalk During Skeletal Muscle Regeneration Thyroid 2021-01-01 [PMID: 32787533]
• B Lee, H Shin, JE Oh, J Park, M Park, SC Yang, JH Jun, SH Hong, H Song, HJ Lim An autophagic deficit in the uterine vessel microenvironment provokes hyperpermeability through deregulated VEGFA, NOS1, and CTNNB1 Autophagy, 2020-06-17;0(0):1-18. 2020-06-17 [PMID: 32579471] (Western Blot, Mouse)
• Pieter R Norden, Amélie Sabine, Ying Wang, Cansaran Saygili Demir, Ting Liu, Tatiana V Petrova et al. Shear stimulation of FOXC1 and FOXC2 differentially regulates cytoskeletal activity during lymphatic valve maturation eLife 2020-06-08 [PMID: 32510325]
• JR Krambs, G Abou Ezzi, JC Yao, DC Link Canonical signaling by TGF family members in mesenchymal stromal cells is dispensable for hematopoietic niche maintenance under basal and stress conditions PLoS ONE, 2020-05-29;15(5):e0233751. 2020-05-29 [PMID: 32470079] (IHC, Mouse)
• Z Wang, F Wang, J Zhong, T Zhu, Y Zheng, T Zhao, Q Xie, F Ma, R Li, Q Tang, F Xu, X Tian, J Zhu Using apelin-based synthetic Notch receptors to detect angiogenesis and treat solid tumors Nat Commun, 2020-05-01;11(1):2163. 2020-05-01 [PMID: 32358530] (ICC, Mouse)
• KL Betterman, DL Sutton, GA Secker, J Kazenwadel, A Oszmiana, L Lim, N Miura, L Sorokin, BM Hogan, ML Kahn, H McNeill, NL Harvey Atypical cadherin Fat4 orchestrates lymphatic endothelial cell polarity in response to flow J. Clin. Invest., 2020-06-01;0(0):. 2020-06-01 [PMID: 32182215] (IHC, Mouse)
• Lilian Schimmel, Daisuke Fukuhara, Mark Richards, Yi Jin, Patricia Essebier, Emmanuelle Frampton et al. c-Src controls stability of sprouting blood vessels in the developing retina independently of cell-cell adhesion through focal adhesion assembly Development 2020-04-01 [PMID: 32108024]
• Eric Engelbrecht, Michel V Levesque, Liqun He, Michael Vanlandewijck, Anja Nitzsche, Hira Niazi et al. Sphingosine 1-phosphate-regulated transcriptomes in heterogenous arterial and lymphatic endothelium of the aorta eLife 2020-02-24 [PMID: 32091396]
• Yanagida K, Engelbrecht E, Niaudet C et al. Sphingosine 1-Phosphate Receptor Signaling Establishes AP-1 Gradients to Allow for Retinal Endothelial Cell Specialization Dev. Cell 3/23/2020 [PMID: 32059774]
• TK Darling, PN Mimche, C Bray, B Umaru, LM Brady, C Stone, CE Eboumbou M, TE Lane, LS Ayong, TJ Lamb EphA2 contributes to disruption of the blood-brain barrier in cerebral malaria PLoS Pathog., 2020-01-30;16(1):e1008261. 2020-01-30 [PMID: 31999807] (IHC, Mouse)
• Wenjuan Pu, Ximeng Han, Lingjuan He, Yan Li, Xiuzhen Huang, Mingjun Zhang et al. A genetic system for tissue-specific inhibition of cell proliferation Development 2020-01-01 [PMID: 31988189]
• JH Wu, YN Li, AQ Chen, CD Hong, CL Zhang, HL Wang, YF Zhou, PC Li, Y Wang, L Mao, YP Xia, QW He, HJ Jin, ZY Yue, B Hu Inhibition of Sema4D/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy EMBO Mol Med, 2020-01-13;12(2):e10154. 2020-01-13 [PMID: 31943789] (Western Blot, Mouse)
• Robert Luck, Severino Urban, Andromachi Karakatsani, Eva Harde, Sivakumar Sambandan, LaShae Nicholson et al. VEGF/VEGFR2 signaling regulates hippocampal axon branching during development eLife 2019-12-23 [PMID: 31868583]
• Cao Nguyen Duong, Astrid F. Nottebaum, Stefan Butz, Stefan Volkery, Dagmar Zeuschner, Martin Stehling et al. Interference With ESAM (Endothelial Cell-Selective Adhesion Molecule) Plus Vascular Endothelial-Cadherin Causes Immediate Lethality and Lung-Specific Blood Coagulation Arteriosclerosis, Thrombosis, and Vascular Biology 2020-02-01 [PMID: 31826650]
• G Chiaverina, L di Blasio, V Monica, M Accardo, M Palmiero, B Peracino, M Vara-Messl, A Puliafito, L Primo Dynamic Interplay between Pericytes and Endothelial Cells during Sprouting Angiogenesis Cells, 2019-09-19;8(9):. 2019-09-19 [PMID: 31546913] (IHC, Mouse)
• Xianghu Qu, Kate Violette, M. K. Sewell-Loftin, Jonathan Soslow, LeShana Saint-Jean, Robert B. Hinton et al. Loss of flow responsive Tie1 results in Impaired Aortic valve remodeling Developmental Biology 2019-11-01 [PMID: 31319059]
• J Zhang, T Supakornde, JR Krambs, M Rao, G Abou-Ezzi, RY Ye, S Li, K Trinkaus, DC Link Bone marrow dendritic cells regulate hematopoietic stem/progenitor cell trafficking J. Clin. Invest., 2019-04-30;129(7):2920-2931. 2019-04-30 [PMID: 31039135] (IHC, Mouse)
• X Han, Y Wang, W Pu, X Huang, L Qiu, Y Li, W Yu, H Zhao, X Liu, L He, L Zhang, Y Ji, J Lu, KO Lui, B Zhou Lineage Tracing Reveals the Bipotency of SOX9+ Hepatocytes during Liver Regeneration Stem Cell Reports, 2019-02-14;12(3):624-638. 2019-02-14 [PMID: 30773487] (IHC, Mouse)
• Guo L, Fernandez R, Sakamoto A et al. Vascular Permeability Assay in Human Coronary and Mouse Brachiocephalic Arteries. Stem Cells International. 11/11/2018 [PMID: 30613761]
• Shuhong Hu, Yifei Liu, Tao You, Li Zhu Semaphorin 7A Promotes VEGFA/VEGFR2-Mediated Angiogenesis and Intraplaque Neovascularization in ApoE-/- Mice Frontiers in Physiology 11/30/2018 [PMID: 30555351]
• Alice Plein, Alessandro Fantin, Laura Denti, Jeffrey W. Pollard, Christiana Ruhrberg Erythro-myeloid progenitors contribute endothelial cells to blood vessels Nature 2018-10-11 [PMID: 30258231]
• G Eelen, C Dubois, AR Cantelmo, J Goveia, U Brüning, M DeRan, G Jarugumill, J van Rijsse, G Saladino, F Comitani, A Zecchin, S Rocha, R Chen, H Huang, S Vandekeere, J Kalucka, C Lange, F Morales-Ro, B Cruys, L Treps, L Ramer, S Vinckier, K Brepoels, S Wyns, J Souffreau, L Schoonjans, WH Lamers, Y Wu, J Haustraete, J Hofkens, S Liekens, R Cubbon, B Ghesquière, M Dewerchin, FL Gervasio, X Li, JD van Buul, X Wu, P Carmeliet Role of glutamine synthetase in angiogenesis beyond glutamine synthesis Nature, 2018-08-29;561(7721):63-69. 2018-08-29 [PMID: 30158707] (IHC, Mouse)
• Emanuel Harari, Liang Guo, Samantha L. Smith, Ka Hyun Paek, Raquel Fernandez, Atsushi Sakamoto et al. Direct Targeting of the mTOR (Mammalian Target of Rapamycin) Kinase Improves Endothelial Permeability in Drug-Eluting Stents—Brief Report Arteriosclerosis, Thrombosis, and Vascular Biology 2018-09-01 [PMID: 30026269]
• Stephan Niland, Dorde Komljenov, Jadranka Macas, Thilo Bracht, Tobias Bäuerle, Stefan Liebner, Johannes A Eble Rhodocetin-?? selectively breaks the endothelial barrier of the tumor vasculature in HT1080 fibrosarcoma and A431 epidermoid carcinoma tumor models. Oncotarget, 2018-04-27;0(0):1949-2553. 2018-04-27 [PMID: 29854288] (IHC, Mouse)
• KG Blecharz-L, V Prinz, M Burek, D Frey, T Schenkel, SM Krug, M Fromm, P Vajkoczy Gelatinolytic activity of autocrine matrix metalloproteinase-9 leads to endothelial de-arrangement in Moyamoya disease J. Cereb. Blood Flow Metab., 2018-04-10;0(0):271678X187684. 2018-04-10 [PMID: 29633884] (ICC, Mouse)
• I Milo, R Blecher-Go, Z Barnett-It, R Bar-Ziv, O Tal, I Gurevich, T Feferman, I Drexler, I Amit, P Bousso, G Shakhar The bone marrow is patrolled by NK cells that are primed and expand in response to systemic viral activation Eur. J. Immunol., 2018-05-02;0(0):. 2018-05-02 [PMID: 29624673] (IHC-Fr, Mouse)
• L Guo, H Akahori, E Harari, SL Smith, R Polavarapu, V Karmali, F Otsuka, RL Gannon, RE Braumann, MH Dickinson, A Gupta, AL Jenkins, MJ Lipinski, J Kim, P Chhour, PS de Vries, H Jinnouchi, R Kutys, H Mori, MD Kutyna, S Torii, A Sakamoto, CU Choi, Q Cheng, ML Grove, MA Sawan, Y Zhang, Y Cao, FD Kolodgie, DP Cormode, DE Arking, E Boerwinkle, AC Morrison, J Erdmann, N Sotoodehni, R Virmani, AV Finn CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis J. Clin. Invest., 2018-02-19;0(0):. 2018-02-19 [PMID: 29457790] (IHC, Human)
• J Cao, M Ehling, S März, J Seebach, K Tarbashevi, T Sixta, ME Pitulescu, AC Werner, B Flach, E Montanez, E Raz, RH Adams, H Schnittler Polarized actin and VE-cadherin dynamics regulate junctional remodelling and cell migration during sprouting angiogenesis Nat Commun, 2017-12-20;8(1):2210. 2017-12-20 [PMID: 29263363] (IHC, Mouse, Rat)
• J Hu, S Dziumbla, J Lin, SI Bibli, S Zukunft, J de Mos, K Awwad, T Frömel, A Jungmann, K Devraj, Z Cheng, L Wang, S Fauser, CG Eberhart, A Sodhi, BD Hammock, S Liebner, OJ Müller, C Glaubitz, HP Hammes, R Popp, I Fleming Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy Nature, 2017-12-06;552(7684):248-252. 12/6/2017 [PMID: 29211719]
• KM Tsang, JS Hyun, KT Cheng, M Vargas, D Mehta, M Ushio-Fuka, L Zou, KV Pajcini, J Rehman, AB Malik Embryonic Stem Cell Differentiation to Functional Arterial Endothelial Cells through Sequential Activation of ETV2 and NOTCH1 Signaling by HIF1? Stem Cell Reports, 2017-08-03;0(0):. 2017-08-03 [PMID: 28781077] (Flow Cytometry, Mouse)
• Luo M, Flood EC, Almeida D et al. Annexin A2 supports pulmonary microvascular integrity by linking vascular endothelial cadherin and protein tyrosine phosphatases J. Exp. Med. 7/10/2017 [PMID: 28694388]
• AJ Mead, WH Neo, N Barkas, S Matsuoka, A Giustacchi, R Facchini, S Thongjuea, L Jamieson, CAG Booth, N Fordham, C Di Genua, D Atkinson, O Chowdhury, E Repapi, N Gray, S Kharazi, SA Clark, T Bouriez, P Woll, T Suda, C Nerlov, SEW Jacobsen Niche-mediated depletion of the normal hematopoietic stem cell reservoir by Flt3-ITD-induced myeloproliferation J. Exp. Med., 2017-06-21;0(0):. 2017-06-21 [PMID: 28637883] (IHC, Mouse)
• L Tian, A Goldstein, H Wang, H Ching Lo, I Sun Kim, T Welte, K Sheng, LE Dobrolecki, X Zhang, N Putluri, TL Phung, SA Mani, F Stossi, A Sreekumar, MA Mancini, WK Decker, C Zong, MT Lewis, XH Zhang Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming Nature, 2017-04-03;0(0):. 2017-04-03 [PMID: 28371798] (IHC, Mouse)
• HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver JCI Insight, 2016-12-22;1(21):e87058. 2016-12-22 [PMID: 28018969] (IHC-Fr, Mouse)
• Haixia Gong, Shejuan An, Antonia Sassmann, Menglin Liu, Victoria Mastej, Manish Mittal et al. PAR1 Scaffolds TGF beta RII to Downregulate TGF-beta Signaling and Activate ESC Differentiation to Endothelial Cells Stem Cell Reports 2016-12-01 [PMID: 27866874] (Flow Cytometry, Mouse)
• Endothelial cells are progenitors of cardiac pericytes and vascular smooth muscle cells Nat Commun, 2016-08-12;7(0):12422. 2016-08-12 [PMID: 27516371] (IHC-Fr, Mouse)
• Jingzhu Zhang Targeting of Mesenchymal Stromal Cells by Cre-Recombinase Transgenes Commonly Used to Target Osteoblast Lineage Cells J Bone Miner Res, 2016-06-14;0(0):. 2016-06-14 [PMID: 27237054] (IHC, Mouse)
• Foxc1 and Foxc2 deletion causes abnormal lymphangiogenesis and correlates with ERK hyperactivation J Clin Invest, 2016-05-23;0(0):. 5/23/2016 [PMID: 27214551]
• Liu Q, Yang R, Huang X, Zhang H, He L, Zhang L, Tian X, Nie Y, Hu S, Yan Y, Zhang L, Qiao Z, Wang Q, Lui K, Zhou B Genetic lineage tracing identifies in situ Kit-expressing cardiomyocytes. Cell Res, 2015-12-04;26(1):119-30. 2015-12-04 [PMID: 26634606] (IHC-Fr, Mouse)
• Shen Y, Cheng F, Sharma M, Merkulova Y, Raithatha S, Parkinson L, Zhao H, Westendorf K, Bohunek L, Bozin T, Hsu I, Ang L, Williams S, Bleackley R, Eriksson J, Seidman M, McManus B, Granville D Granzyme B Deficiency Protects against Angiotensin II-Induced Cardiac Fibrosis. Am J Pathol, 2015-11-25;186(1):87-100. 2015-11-25 [PMID: 26610869] (IHC-P, Western Blot, Mouse)
• Yin H, Frontini M, Arpino J, Nong Z, O'Neil C, Xu Y, Balint B, Ward A, Chakrabarti S, Ellis C, Gros R, Pickering J Fibroblast Growth Factor 9 Imparts Hierarchy and Vasoreactivity to the Microcirculation of Renal Tumors and Suppresses Metastases. J Biol Chem, 2015-07-16;290(36):22127-42. 2015-07-16 [PMID: 26183774] (IHC-P, Mouse)
• Zang G, Gustafsson K, Jamalpour M, Hong J, Genove G, Welsh M Vascular dysfunction and increased metastasis of B16F10 melanomas in Shb deficient mice as compared with their wild type counterparts. BMC Cancer, 2015-04-08;15(0):234. 2015-04-08 [PMID: 25885274] (IHC, Mouse)
• Shahin Rafii, Zhongwei Cao, Raphael Lis, Ilias I. Siempos, Deebly Chavez, Koji Shido et al. Platelet-derived SDF-1 primes the pulmonary capillary vascular niche to drive lung alveolar regeneration Nature Cell Biology 2015-02-01 [PMID: 25621952] (Western Blot)
• Samarelli A, Riccitelli E, Bizzozero L, Silveira T, Seano G, Pergolizzi M, Vitagliano G, Cascone I, Carpentier G, Bottos A, Primo L, Bussolino F, Arese M Neuroligin 1 induces blood vessel maturation by cooperating with the alpha6 integrin. J Biol Chem, 2014-05-23;289(28):19466-76. 2014-05-23 [PMID: 24860089] (IHC, Mouse)
• Stoler-Barak , Liat, Moussion , Christin, Shezen , Elias, Hatzav , Miki, Sixt , Michael, Alon , Ronen Blood vessels pattern heparan sulfate gradients between their apical and basolateral aspects. PLoS ONE, 2014-01-22;9(1):e85699. 2014-01-22 [PMID: 24465652] (IHC, Mouse)
• Kohler , Erin E, Wary , Kishore, Li , Fei, Chatterjee , Ishita, Urao , Norifumi, Toth , Peter T, Ushio-Fukai , Masuko, Rehman , Jalees, Park , Changwon, Malik , Asrar B Flk1+ and VE-cadherin+ endothelial cells derived from iPSCs recapitulates vascular development during differentiation and display similar angiogenic potential as ESC-derived cells. PLoS ONE, 2013-12-30;8(12):e85549. 2013-12-30 [PMID: 24386480] (Flow Cytometry, ICC, Mouse)
• Lu , Zhi Hong, Kaliberov , Sergey, Sohn , Rebecca, Kaliberova , Lyudmila, Curiel , David T, Arbeit , Jeffrey Transcriptional targeting of primary and metastatic tumor neovasculature by an adenoviral type 5 roundabout4 vector in mice. PLoS ONE, 2013-12-23;8(12):e83933. 2013-12-23 [PMID: 24376772] (Western Blot, Mouse)
• Bowles J, Secker G, Nguyen C, Kazenwadel J, Truong V, Frampton E, Curtis C, Skoczylas R, Davidson T, Miura N, Hong Y, Koopman P, Harvey N, Francois M Control of retinoid levels by CYP26B1 is important for lymphatic vascular development in the mouse embryo. Dev Biol, 2013-12-19;386(1):25-33. 2013-12-19 [PMID: 24361262] (IHC-Fr, Mouse)
• Ding B, Cao Z, Lis R, Nolan D, Guo P, Simons M, Penfold M, Shido K, Rabbany S, Rafii S Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis. Nature, 2013-11-20;505(7481):97-102. 2013-11-20 [PMID: 24256728] (IHC, Mouse)
• Wilson CW, Parker LH, Hall CJ et al. Rasip1 regulates vertebrate vascular endothelial junction stability through Epac1-Rap1 signaling. Blood. 11/21/2013 [PMID: 23886837]
• Sun Z, Li X, Massena S, Kutschera S, Padhan N, Gualandi L, Sundvold-Gjerstad V, Gustafsson K, Choy WW, Zang G, Quach M, Jansson L, Phillipson M, Abid MR, Spurkland A, Claesson-Welsh L VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. J. Exp. Med., 2012-06-11;209(7):1363-77. 2012-06-11 [PMID: 22689825] (IHC, Western Blot, Mouse)
• Cyrill Géraud, Konstantin Evdokimov, Beate K. Straub, Wiebke K. Peitsch, Alexandra Demory, Yvette Dörflinger et al. Unique Cell Type-Specific Junctional Complexes in Vascular Endothelium of Human and Rat Liver Sinusoids PLoS ONE 2012-04-03 [PMID: 22509281]
• Marrotte EJ, Chen DD, Hakim JS Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice. J. Clin. Invest., 2010-11-08;120(12):4207-19. 2010-11-08 [PMID: 21060152] (Flow Cytometry, Mouse)
• Butler JM, Nolan DJ, Vertes EL, Varnum-Finney B, Kobayashi H, Hooper AT, Seandel M, Shido K, White IA, Kobayashi M, Witte L, May C, Shawber C, Kimura Y, Kitajewski J, Rosenwaks Z, Bernstein ID, Rafii S Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell, 2010-03-05;6(3):251-64. 2010-03-05 [PMID: 20207228] (ICC, IHC-Fr, IHC-P, Mouse)
• Funa NS, Kriz V, Zang G, Calounova G, Akerblom B, Mares J, Larsson E, Sun Y, Betsholtz C, Welsh M Dysfunctional microvasculature as a consequence of shb gene inactivation causes impaired tumor growth. Cancer Res., 2009-02-17;69(5):2141-8. 2009-02-17 [PMID: 19223532] (IHC, Mouse)
• Mazzone M, Dettori D, Leite de Oliveira R, Loges S, Schmidt T, Jonckx B, Tian YM, Lanahan AA, Pollard P, Ruiz de Almodovar C, De Smet F, Vinckier S, Aragones J, Debackere K, Luttun A, Wyns S, Jordan B, Pisacane A, Gallez B, Lampugnani MG, Dejana E, Simons M, Ratcliffe P, Maxwell P, Carmeliet P Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell, 2009-02-12;136(5):839-51. 2009-02-12 [PMID: 19217150] (ICC, Mouse)
• Cordey M, Limacher M, Kobel S, Taylor V, Lutolf MP Enhancing the reliability and throughput of neurosphere culture on hydrogel microwell arrays. Stem Cells, 2008-07-31;26(10):2586-94. 2008-07-31 [PMID: 18669905] (ICC, IHC-Fr, Mouse)
• Watanabe M, Boyer JL, Hackett NR, Qiu J, Crystal RG Genetic delivery of the murine equivalent of bevacizumab (avastin), an anti-vascular endothelial growth factor monoclonal antibody, to suppress growth of human tumors in immunodeficient mice. Hum. Gene Ther., 2008-03-01;19(3):300-10. 2008-03-01 [PMID: 18324912] (IHC-P, Mouse)
• Li X, Edholm D, Lanner F, Breier G, Farnebo F, Dimberg A, Claesson-Welsh L Lentiviral rescue of vascular endothelial growth factor receptor-2 expression in flk1-/- embryonic stem cells shows early priming of endothelial precursors. Stem Cells, 2007-08-16;25(12):2987-95. 2007-08-16 [PMID: 17702981] (ICC, Mouse)
• Rutland CS, Latunde-Dada AO, Thorpe A, Plant R, Langley-Evans S, Leach L Effect of gestational nutrition on vascular integrity in the murine placenta. Placenta, 2006-08-23;28(7):734-42. 2006-08-23 [PMID: 16930688] (IHC, Mouse)

Reviews for VE-Cadherin Antibody (AF1002) (3)

Average Rating: 4.3

(Based on 3 reviews)

We have 3 reviews tested in 1 species: Mouse.

reviewed by: Bhavin Shah Immunofluorescence-frozen sections Mouse 04/28/2020

Summary

• Application: Other
• Sample Tested: Embryonic brain
• Species: Mouse
• Lot: FQI0117051

Comments

• Comments: Tissue sections were thawed and blocked in 10% NDS in PBST for 2 hours.
  Primary ( 4degrees Overnight ) and secondary (2 hours at RT) were prepared in the same blocking buffer.

reviewed by: Hongyan Zhao IHC-Fr Mouse 03/12/2015

Summary

• Application: Immunohistochemistry-Frozen
• Sample Tested: Mouse
• Species: Mouse
• Lot: FQ10113071

reviewed by: Hongyan Zhao WB Mouse 02/25/2015

Summary

• Application: Western Blot
• Sample Tested: Protein
• Species: Mouse
• Lot: FQ10113071

Bioinformatics

• Gene Symbol: CDH5
• Uniprot:
  • 2208309A()